News & Updates

Thiel joins leading investors Stefan Roever and BlueTree Ventures in Series A round Company appoints Sanjay Kakkar as Chief Executive Officer

Peptilogics, a pre-clinical stage company utilizing an innovative peptide platform to treat multidrug-resistant bacterial infections, announced today that it closed a $5.5 million Series A financing with participation from Peter Thiel, Stefan Roever, BlueTree Ventures and others. Peptilogics, founded by Jonathan Steckbeck, who serves as President and Chief Scientif...

Please reload

© 2020 Peptilogics  I  All Rights Reserved